drugset / Trial / NCT05151679

Chelated Oral Iron Versus Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia Late in Pregnancy

NCT05151679

Expanded access Available Assiut University

Summary

compare the efficacy and safety of intravenous iron sucrose versus chelated oral iron in the treatment of iron deficiency anemia late in pregnancy.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Chelated Iron Unknown 200 mg Intravenous
Subject Iron sucrose Unknown 15 mg Oral